Tenderwize
Retour à la recherche

Lanthanum Carbonate Chewable Tablets

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline May 30, 2028 · 640 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Lanthan(III)-carbonat (ATC: V03AE03 - in der Darreichungsform Kautabletten)

61/100

Score d'opportunité

PromisingMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

61 / 100

Complexité

42 / 100

Facteurs de risque

The structured deadline/fallback date (30.05.2028 22:00) differs from the XML end date/occurrence date (31.05.2028 00:0...

Structured data says electronicSubmission = not-allowed, while the XML text says contract documents may be sent by emai...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply / rebate agreement for pharmaceutical products containing lanthanum(III)-carbonate in chewable tablet form.
  • Open-house model with uniform contract terms and equal access for interested pharmaceutical companies.
Afficher le résumé complet

This is an open-house style pharmaceutical supply notice by AOK Sachsen-Anhalt for non-exclusive rebate agreements on lanthanum(III) carbonate chewable tablets (ATC V03AE03). The contract can be joined at any time on the same terms, with no individual negotiations, and the term runs until 31.07.2028. The notice provides a document URL and explicitly allows submission of signed contract documents by email or post, but the procedure is described as not a public contract under GWB despite being published in TED.

Risques

The structured deadline/fallback date (30.05.2028 22:00) differs from the XML end date/occurrence date (31.05.2028 00:0...

Structured data says electronicSubmission = not-allowed, while the XML text says contract documents may be sent by emai...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Interested pharmaceutical companies must request the participation documents and the contract from the contact address.
  • The participation documents must be fully completed and signed.
  • The notice states that the contract documents may be submitted either by post or electronically as a PDF with a qualified electronic signature.

Acheteur

Localisation

Magdeburg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE258393558

Activité

Health

Lots (1)

LOT-0001

Lanthanum Carbonate Chewable Tablets

Non-exclusive rebate agreement for finished medicinal products containing lanthanum(III) carbonate (ATC V03AE03) in chewable tablet form. The open-house model means any eligible pharmaceutical company may join at any time under uniform terms; no exclusivity and no individual negotiations. This lot information is taken from structured data and the notice text.

SuppliesEU fundedElectronic submission

Localisation

DEE03, Germany

Durée

2 YEAR

Catégorie

Pharmaceutical products

Date limite

Deadline May 30, 2028

Détails de la procédure

Date de publication
08 Jun 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
394434-2026

Documents (1)

Appels d'offres similaires